news Therapies targeting AhRs and IDO1 could combat COVID-19, paper says 30 June 2020 | By Victoria Rees (Drug Target Review) Researchers have hypothesised that treatments targeting the downregulation of AhRs and IDO1 genes could reduce severity of COVID-19 infection.
news RhoA protein function identified in nerve cell development 4 November 2019 | By Drug Target Review A recent study has revealed new findings about nerve cell development that could help to facilitate future treatment options for spinal cord injuries.
news Anle138b blocks toxic ion flow linked to Alzheimer’s disease 5 December 2017 | By Dr Zara Kassam (Drug Target Review) A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease by stopping toxic ion flow in the brain...
news New potential strategy to combat Alzheimer’s disease 1 September 2017 | By Dr Zara Kassam (Drug Target Review) Researchers have revealed the molecular mechanism behind a rare mutation has been associated with numerous neurodegenerative diseases...